TY - JOUR
T1 - Highly specific marker genes for detecting minimal gastric cancer cells in cytology negative peritoneal washings
AU - Mori, Kazuhiko
AU - Aoyagi, Kazuhiko
AU - Ueda, Tetsuya
AU - Danjoh, Inaho
AU - Tsubosa, Yasuhiro
AU - Yanagihara, Kazuyoshi
AU - Matsuno, Yoshihiro
AU - Sasako, Mitsuru
AU - Sakamoto, Hiromi
AU - Mafune, Ken Ichi
AU - Kaminishi, Michio
AU - Yoshida, Teruhiko
AU - Terada, Masaaki
AU - Sasaki, Hiroki
N1 - Funding Information:
We thank Mr. K. Nomoto (Clinical Laboratory Division, National Cancer Center Hospital) for his excellent technical assistance in conventional cytology. This work was supported by a Grant-in-Aid for the Second Comprehensive 10-Year Strategy for Cancer Control from the Ministry of Health, Labor and Welfare of Japan; and by the Program for the Promotion of Fundamental Studies in Health Science of the Organization for Pharmaceutical Safety and Research of Japan. K. Mori is an awardee of Research Resident Fellowships from the Foundation for Promotion of Cancer Research.
Copyright:
Copyright 2017 Elsevier B.V., All rights reserved.
PY - 2004/1/23
Y1 - 2004/1/23
N2 - Peritoneal wash cytology plays a pivotal role in the decision for gastric cancer treatment because advanced gastric cancer often turns out incurable with peritoneal metastasis. Molecular detection of minimal cancer cells from peritoneal washings may overcome the sensitivity boundary of conventional cytology and contribute to the prediction of the disease outcome. To select marker candidates out of ten thousands of genes, we performed microarray analyses in 12 gastric cell lines and 8 peritoneal washings of early stage cases. With 40 candidates selected by the above expression profiling, RT-PCR in 16 representative peritoneal wash samples was performed to identify genes specific to cytology positive samples. The finally selected five genes, CK20, FABP1, MUC2, TFF1, and TFF2, were then evaluated for their utility as a marker for minimal residual disease in 99 peritoneal wash samples. Nested RT-PCR using the five genes showed positive results highly specific to incurable cases (91-100%). With a high specificity, the combination of these five genes succeeded in identifying 6 out of 20 (30%) additional patients with all types of early recurrence that could not be predicted by the conventional method. The six newly identified recurrences included four non-peritoneal ones, showing that RT-PCR using the five genes without a real-time quantitative PCR technique contributes to the detection of minimal residual disease.
AB - Peritoneal wash cytology plays a pivotal role in the decision for gastric cancer treatment because advanced gastric cancer often turns out incurable with peritoneal metastasis. Molecular detection of minimal cancer cells from peritoneal washings may overcome the sensitivity boundary of conventional cytology and contribute to the prediction of the disease outcome. To select marker candidates out of ten thousands of genes, we performed microarray analyses in 12 gastric cell lines and 8 peritoneal washings of early stage cases. With 40 candidates selected by the above expression profiling, RT-PCR in 16 representative peritoneal wash samples was performed to identify genes specific to cytology positive samples. The finally selected five genes, CK20, FABP1, MUC2, TFF1, and TFF2, were then evaluated for their utility as a marker for minimal residual disease in 99 peritoneal wash samples. Nested RT-PCR using the five genes showed positive results highly specific to incurable cases (91-100%). With a high specificity, the combination of these five genes succeeded in identifying 6 out of 20 (30%) additional patients with all types of early recurrence that could not be predicted by the conventional method. The six newly identified recurrences included four non-peritoneal ones, showing that RT-PCR using the five genes without a real-time quantitative PCR technique contributes to the detection of minimal residual disease.
KW - Gastric cancer
KW - Minimal residual disease
KW - Molecular marker
KW - Peritoneal washing
UR - http://www.scopus.com/inward/record.url?scp=9144232255&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=9144232255&partnerID=8YFLogxK
U2 - 10.1016/j.bbrc.2003.12.025
DO - 10.1016/j.bbrc.2003.12.025
M3 - Article
C2 - 14706632
AN - SCOPUS:9144232255
SN - 0006-291X
VL - 313
SP - 931
EP - 937
JO - Biochemical and Biophysical Research Communications
JF - Biochemical and Biophysical Research Communications
IS - 4
ER -